Home » Topics » BioWorld Science

BioWorld Science
RSS

Albireo Pharma presents preclinical data on HBV entry inhibitor A-2342

Nov. 23, 2021

Simcere and SIMM collaborate to develop novel oral antivirals for COVID-19

Nov. 22, 2021

BTT-105 ameliorates hepatic fibrosis in NAFLD animal model

Nov. 22, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces HBsAg levels in vivo

Nov. 22, 2021

AL-009 shows antitumor efficacy both as monotherapy and in combination with anti-PD-L1

Nov. 22, 2021

U.S. researchers divulge new PI3K-alpha inhibitors

Nov. 22, 2021

Recurium IP Holdings presents new PROTACs for cancer

Nov. 22, 2021

Janssen Pharmaceutica synthesizes new IL-17A/IL-17RA interaction modulators

Nov. 22, 2021

Eli Lilly patents new Ret inhibitors

Nov. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...